Advocating for malaria elimination - learning from the successes of other infectious disease elimination programmes
Whittaker, Maxine A., Dean, Angela J., and Chancellor, Arna (2014) Advocating for malaria elimination - learning from the successes of other infectious disease elimination programmes. Malaria Journal, 13. 221. pp. 1-8.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution. Download (375kB) | Preview |
Abstract
Malaria elimination is back on the agenda, but it remains challenging for countries to make the transition from effective control to elimination. Many other infectious diseases have been targeted by globally-coordinated elimination advocacy campaigns, and advocacy has been considered an essential component of the success of other disease elimination programmes. What can the malaria community learn from these successes? A review of infectious disease elimination programmes to identify successful elements of advocacy for disease elimination was undertaken. Key elements are: (i) a global elimination plan, supported by international health bodies; (ii) thorough costings and tools to support the business case; (iii) an approach that is positioned within a development framework; (iv) core elimination advocacy messages; (v) provision of advocacy tools for partners (vi) extensive and effective community engagement; and (vii) strong partnerships. These features provide insights into 'what works' in global elimination advocacy. Advocacy is a powerful tool to support the long-term political and financial commitment necessary for malaria elimination. The global malaria community needs to work together, to ensure that the early steps towards the end goal of malaria elimination are taken.
| Item ID: | 43853 |
|---|---|
| Item Type: | Article (Research - C1) |
| ISSN: | 1475-2875 |
| Keywords: | malaria, malaria elimination, disease eradication, health communication, public-private sector partnerships, advocacy, community engagement, global health planning international development |
| Additional Information: | © Whittaker et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| Funders: | Bill and Melinda Gates Foundation (BMGF) |
| Date Deposited: | 21 Jul 2016 23:30 |
| FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110309 Infectious Diseases @ 100% |
| SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920109 Infectious Diseases @ 50% 92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920499 Public Health (excl. Specific Population Health) not elsewhere classified @ 50% |
| Downloads: |
Total: 1008 Last 12 Months: 3 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |